7th China (Shenzhen) Innovation & Entrepreneurship International Competition
The 7th China (Shenzhen) Innovation & Entrepreneurship International Competition (“IEIC”) is the largest international innovation and entrepreneurship competition in Shenzhen, China and attracts startups and innovation talents from all over the world. Cambridge Hacklab Academy Ltd as co-organizer in IEIC UK division sincerely invite start-ups and entrepreneurs to join in the event this year!
Men's Health Week and Corazon's Charity of the Year
Today is the start of Men's Health Week and a joint effort is required to change attitudes to men's mental health.
Metrion Biosciences appoints Dr Steve Jenkinson as VP, Drug Discovery and Safety Assessment to strengthen US operations
Appointment supports growth of Metrion’s pre-clinical ion channel contract research and safety pharmacology services.
Human capabilities vs skills: the answer to hard to fill vacancies?
Are hard-to-fill job vacancies keeping you up at night? If you’re struggling to find the right candidates for the right roles, you might be asking yourself where you’re going wrong. But the talent is out there – all we need is a fresh approach to finding them.
World-first NHS test to curb transfusion side-effects for thousands with Inherited Blood Disorders
The NHS is set to introduce a new genetic blood-matching test – developed through a collaboration with partners including the NIHR BioResource - for thousands living with sickle-cell disease or thalassaemia that could reduce some of the side-effects of transfusion treatments.
Study involving BioResource volunteers finds that obesity accelerates loss of COVID-19 vaccination immunity
Following publication of a new study led by scientists at the Universities of Cambridge and Edinburgh, we asked co-lead of the Cambridge team, Dr James Thaventhiran, about the role of the BioResource and our volunteers in facilitating this study that suggests people with obesity are likely to need more frequent COVID-19 booster doses to maintain immunity.
H.E.L Group expands range of BioXplorer bioreactors to support bioprocess development
Automated parallel bioreactor offering updated with increased capabilities for multi-parameter process development BioXplorer systems are modular and highly configurable with automation, process control, safety monitoring, and data recording enabled through controlCambridge Healthcare Research Appoints the Head of their Competitive Intelligence Division, Solici
Cambridge Healthcare Research announces the promotion of Senior Principal Brendan Walkden to Head of Solici
The importance of getting a workplace investigation right
The importance of conducting a workplace investigation correctly and fairly is paramount, with this only being achieved with the correct polices and procedures being implemented and followed.
Axol Bioscience collaborates with StrataStem to deliver stem cell based ‘Clinical Trial in a Dish’ for Alzheimer’s Disease
Together, an extensive panel of consented patient samples and iPSC technology will advance AD drug development and patient stratification.
ELRIG UK Announces Prof Janet Hemingway and Dr Dave Powell as Keynote Speakers at Drug Discovery 2023
ELRIG Drug Discovery 2023 at ACC Liverpool (18–19 October) to focus on diverse thinking and new perspectives
CN Bio appoints Dr. Samantha Macro as Chief Financial Officer
Key executive appointment provides extensive financial industry experience as the Company implements ambitious global growth strategy
New horizons for Guardtech Group as international presence continues to grow
Cleanroom construction specialists establishing their brands overseas with string of exciting European projects
Avacta Achieves Second Milestone in AffyXell Joint Venture Triggering Increased Equity Stake
Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, is pleased to announce that a second milestone equity payment has been triggered resulting in an increase in Avacta’s shareholding in AffyXell Therapeutics ("AffyXell"),
Epicentre, Haverhill to run “coping with menopausal symptoms” sessions
The EpiCentre at Haverhill is to run a series of 90-minute sessions to help women who struggle with menopausal symptoms.
Pangaea Data awarded strategic partnership by Mersey Care NHS Foundation Trust and the University of Liverpool’s Mental Health Research for Innovation Centre (M-RIC)
Pangaea Data awarded strategic partnership by Mersey Care NHS Foundation Trust and the University of Liverpool’s Mental Health Research for Innovation Centre (M-RIC) to characterize patients across hard-to-diagnose mental health conditions.
Avacta acquires Coris Bioconcept, adding a broad range of marketed professional-use rapid tests to the Group
Acquisition consistent with Avacta Diagnostics M&A strategy and complements earlier acquisition of Launch Diagnostics.
France: A step towards more regulated drug prices
2022 was an expensive year for public spending in France, that led to a €18.9 billion debt for the social security system[1]
Cresset releases Flare™ V7
Flare™ is a comprehensive drug design platform that integrates the power of ligand and
Cellular Origins launches Constellation, its configurable robotic platform to enable scalable manufacture of advanced therapies
Closed, fully automated, and configurable robotic platform for cell therapy manufacture can achieve 30-fold increase in space efficiency and reduces production costs and labour by 51% and 16-fold respectively Scales cell therapy manufacturing without changing the process used in'Prehabilitation’ boosts surgery outcomes – new study
Research finds exercise and education can improve pre and post-op results.
Leading artist powers creativity at new children’s hospital
A world-renowned artist is helping to shape how the region’s first children’s hospital will look and feel – putting creativity at the heart of the new building.
Takeaways from roundtable discussion on Medical Affairs challenges at MAPS 2023 Global Annual Meeting
In spring 2023, CRA’s Life Sciences Practice held a roundtable discussion with Medical Affairs leaders to better understand obstacles prohibiting their teams from achieving their vision, in addition to progress made towards overcoming those obstacles.
Central Pharma joins CSafe’s global partner network of pharma service providers to expand supply chain solutions for the cell and gene therapy market.
Central Pharma Cell And Gene Therapy writes...we are delighted to announce our strategic CGT partnership with CSafe, in a sector we are deeply passionate about.